Financials
- Market Capitalization 2.62 B
- Employee 13
- Founded 2006
- CEO Angelos M. Stergiou
- Website www.sellaslifesciences.com
- Headquarter Delaware, United States
- FIGI BBG000VC77H7
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 1777 | ATAI AtaiBeckley Inc. - Common Stock | 7.34 USD | 0.00% | -0.94% | +2.23% | +85.82% | 2.72 B USD | ||
| 1797 | NRIX Nurix Therapeutics, Inc. - Common stock | 25.69 USD | -0.35% | -5.13% | +11.89% | +129.17% | 2.67 B USD | ||
| 1811 | VRDN Viridian Therapeutics, Inc. - Common Stock | 23.08 USD | -0.35% | -5.76% | +22.77% | +2.81% | 2.61 B USD | ||
| 1833 | RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 25.60 USD | +1.55% | -4.41% | +2.73% | -16.07% | 2.52 B USD |